World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
36808
World Ranking
17359
National Ranking
1569

John Yarnold publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John Yarnold sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 385 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John Yarnold D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John Yarnold sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John Yarnold is affiliated with the Institute of Cancer Research in the United Kingdom and has a substantial research presence in the fields of medicine and biochemistry, genetics, and molecular biology. Their work prominently addresses cancer research, with a strong emphasis on radiation and oncology-related studies.

The scientist's research spans several subfields, including:

  • Cancer Research
  • Radiology, Nuclear Medicine and Imaging
  • Radiation
  • Pulmonary and Respiratory Medicine
  • Oncology

John Yarnold's main topics of research include:

  • Breast Cancer Treatment Studies
  • Advanced Radiotherapy Techniques
  • Advances in Oncology and Radiotherapy
  • Effects of Radiation Exposure
  • Breast Lesions and Carcinomas
  • Cancer, Hypoxia, and Metabolism
  • Nanoplatforms for cancer theranostics

Their publications have appeared frequently in the following venues:

  • Radiotherapy and Oncology
  • The Lancet
  • Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • SSRN Electronic Journal

Among recent papers, John Yarnold is associated with notable works such as:

  • Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial (2020), published in The Lancet
  • Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer (2020), published in Journal of Clinical Oncology
  • Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial (2023), published in The Lancet
  • Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial (2020), published in International Journal of Radiation Oncology*Biology*Physics
  • How Low Can You Go? The Radiobiology of Hypofractionation (2022), published in Clinical Oncology

Frequent co-authorship is an important aspect of John Yarnold's research, collaborating multiple times with the following colleagues:

  • Joanne Haviland
  • Anna M. Kirby
  • Navita Somaiah
  • Judith M. Bliss
  • Adrian Murray Brunt

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

    Joanne S Haviland;Joanne S Haviland;J Roger Owen;John A Dewar;Rajiv K Agrawal

  • The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

    Bentzen Sm;Agrawal Rk;Aird Eg

  • Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

    David P Dearnaley;Vincent S Khoo;Andrew R Norman;Lesley Meyer

  • Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.

    Adrian Murray Brunt;Adrian Murray Brunt;Joanne S Haviland;Duncan A Wheatley;Mark A Sydenham

  • Pathogenetic mechanisms in radiation fibrosis.

    John Yarnold;Marie-Catherine Vozenin Brotons;Marie-Catherine Vozenin Brotons

  • Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

    J Roger Owen;Anita Ashton;Judith M Bliss;Janis Homewood

  • Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial

    John Yarnold;Anita Ashton;Judith M Bliss;Janis Homewood

  • Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

    Charlotte E Coles;Clare L Griffin;Anna M Kirby;Jenny Titley

  • aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

    R G Gray;D Rea;K Handley;S J Bowden

  • Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

    P. Price;P.J. Hoskin;D. Easton;D. Austin

  • ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.

    Birgitte V. Offersen;Liesbeth J. Boersma;Carine Kirkove;Sandra Hol

  • Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy

    Ellen Donovan;Natalie Bleakley;Erica Denholm;Phil Evans

  • Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial

    A Gregor;A Cull;R J Stephens;J A Kirkpatrick

  • The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity

    A.M. Moody;W.P.M. Mayles;J.M. Bliss;R.P. A'Hern

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

  • A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain.

    P.J. Hoskin;P. Price;D. Easton;J. Regan

  • Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

    Penelope Hopwood;Joanne S Haviland;Georges Sumo;Judith Mills

  • ESTABLISHMENT OF A RADIOGENOMICS CONSORTIUM

    Catharine West;Barry S. Rosenstein

  • First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

    Rajiv K Agrawal;Abdulla Alhasso;Peter J Barrett-Lee

Frequent Co-Authors

Judith M. Bliss
Judith M. Bliss Institute of Cancer Research
Søren M. Bentzen
Søren M. Bentzen University of Maryland, Baltimore
Peter Hoskin
Peter Hoskin University of Manchester
Alison M. Dunning
Alison M. Dunning University of Cambridge
Robert E. Coleman
Robert E. Coleman University of Sheffield
Roger A'Hern
Roger A'Hern Royal Marsden NHS Foundation Trust
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Philip Poortmans
Philip Poortmans University of Antwerp
Catharine M L West
Catharine M L West University of Manchester
Andrew Tutt
Andrew Tutt Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in building a medical career beyond the traditional MD, a number of flexible online options are available. Many students are exploring the shortest dnp programs online to quickly advance into leadership or specialized nursing roles, often while continuing to work. These programs can shave months or even years off the time to a doctorate in nursing practice.

Flexibility is a major benefit—students can choose among various dnp programs online that fit their schedules and learning needs. For those looking to start their healthcare career as soon as possible, fast track lpn options can provide a quick pathway into practical nursing and entry-level care positions.

If your interest lies in mental health, several online msn pmhnp programs allow you to train as a Psychiatric Mental Health Nurse Practitioner on an accelerated timeline. Whether you aim to lead, specialize, or start your healthcare career fast, there’s an online pathway to match your goals.

Best Scientists Citing John Yarnold

Trending Scientists

Recently Published Articles